Medical Device Maker Venus Medtech Pumps Up Investors With Prospect of 2021 Profits
Company funds expansion through $400 million share sale as it targets U.S. and EU with growing pipeline of heart valve-replacement products Major Takeaways Venus Medtech’s recent $400 million equity fundraising…
RELATED ARTICLES
-
Property crisis deepens with debt action against Sunac
1918.HK -
Country Garden’s debt restructure hinges on stabilizing property market
2007.HK
-
Cash-hungry Mabwell seeks financial tonic from Hong Kong investors
688062.SHG
-
Gasping Huabao’s profits go up in smoke
0336.HK 300741.SHE
-
Horizon’s lead grows in smart driving race with new product rollouts
9660.HK
